Chronic wounds have emerged as a global public health concern, characterized by prolonged disease course,
poor prognosis, and significant patient healthcare burden. Debridement, as a critical step in wound bed preparation, directly
determines therapeutic outcomes. Enzymatic debridement refers to the selective application of enzymatic agents to necrotic
tissue for targeted debridement. Among these, collagenase-based preparations are the most widely used and evidencesupported
enzymatic debridement agents in clinical practice. They selectively degrade necrotic collagen without damaging
healthy tissue, while also exerting multiple effects such as anti-inflammatory action, modulation of the wound
microenvironment, promotion of granulation tissue formation, and enhancement of epithelialization. This article
systematically reviews the historical development of enzymatic debridement, summarizes the mechanisms of collagenasebased
preparations, and evaluates their clinical applications in burn wounds, diabetic foot ulcers, pressure ulcers, and
vascular occlusive wounds. Furthermore, it provides insights based on the latest guidelines and research advancements to
support standardized clinical practice.